InfuSystem Holdings, Inc. (AMEX:INFU) Q1 2024 Earnings Call Transcript

Page 4 of 4

We can repair the device, we can support it and all that. But when you look at GE, GE was kind of presented to us, it was easy — I shouldn’t say easy. I think Carrie will kill me if I say that, but it was — we knew exactly how to do it. They had a model already built. We just had to go help them execute on that model, right? Pretty easy thing to do. Sanara, TAM-wise is much bigger, right? Wound Care in general is [indiscernible] the lymphedema market. And we have a partner that already has phenomenal products, but I would argue the best in the world from a product line standpoint with a model we can go after. So it’s more than just 1 metric. When you look at the whole picture, and how easy is it to get in the market? What’s the risk for us?

Do we have to stand up sales teams like all of that goes into the thought process. And when we compare lymphedema to these other guys, these other opportunities are just too good. It doesn’t mean lymphedema is off the list, but I don’t see it coming in the next 18 to 24 months. But someday, maybe we do, right? Maybe a partner shows up with a great product and model and they want us to just help them. That’s probably how we would get into that market more so than just us getting a device that we could use and go and do it on our own. It just takes a lot longer, a lot more cost and a lot more risk.

Aaron Warwick: Well, and obviously, you’ve had other opportunities open up because of what you said about GE and Sanara. So exactly it sounds like it opens — well, I know it’s been a bit of a transition for you guys and still going on from that standpoint. But I think it commend you for being willing to be flexible and do what’s best for ultimately, the bottom line. So thank you, guys. Appreciate it.

Operator: And with that, ladies and gentlemen, this concludes our question-and-answer session. I would now like to turn the conference back over to Mr. Richard Dilorio.

Rich Dilorio: I want to thank everyone for participating on today’s call, and we look forward to our second quarter call when we’ll update you on our results and progress with this year’s strategic priorities. Have a great day.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect your lines.

Follow Infusystem Holdings Inc (NYSEMKT:INFU)

Page 4 of 4